Microbix Biosystems Stock Performance
| MBX Stock | CAD 0.30 0.01 3.23% |
The company secures a Beta (Market Risk) of 0.0546, which conveys not very significant fluctuations relative to the market. As returns on the market increase, Microbix Biosystems' returns are expected to increase less than the market. However, during the bear market, the loss of holding Microbix Biosystems is expected to be smaller as well. At this point, Microbix Biosystems has a negative expected return of -0.35%. Please make sure to verify Microbix Biosystems' total risk alpha and the relationship between the potential upside and market facilitation index , to decide if Microbix Biosystems performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Microbix Biosystems has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors. ...more
Ex Dividend Date 1999-09-02 |
1 | Microbix receives EU accreditations for diagnostic products - Yahoo Finance | 10/04/2024 |
2 | Stocks In Play Microbix Biosystems Inc. - Barchart | 11/12/2024 |
| Begin Period Cash Flow | 13.5 M |
Microbix |
Microbix Biosystems Relative Risk vs. Return Landscape
If you would invest 38.00 in Microbix Biosystems on September 4, 2024 and sell it today you would lose (8.00) from holding Microbix Biosystems or give up 21.05% of portfolio value over 90 days. Microbix Biosystems is producing return of less than zero assuming 1.9995% volatility of returns over the 90 days investment horizon. Simply put, 17% of all stocks have less volatile historical return distribution than Microbix Biosystems, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Microbix Biosystems Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Microbix Biosystems' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Microbix Biosystems, and traders can use it to determine the average amount a Microbix Biosystems' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1745
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MBX |
Estimated Market Risk
| 2.0 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.17 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Microbix Biosystems is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Microbix Biosystems by adding Microbix Biosystems to a well-diversified portfolio.
Microbix Biosystems Fundamentals Growth
Microbix Stock prices reflect investors' perceptions of the future prospects and financial health of Microbix Biosystems, and Microbix Biosystems fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Microbix Stock performance.
| Return On Equity | 0.2 | ||||
| Return On Asset | 0.0382 | ||||
| Profit Margin | 0.22 % | ||||
| Operating Margin | 0.03 % | ||||
| Current Valuation | 34.56 M | ||||
| Shares Outstanding | 136.7 M | ||||
| Price To Book | 1.46 X | ||||
| Price To Sales | 1.76 X | ||||
| Revenue | 16.51 M | ||||
| Gross Profit | 11.12 M | ||||
| EBITDA | 1.96 M | ||||
| Net Income | (39.48 K) | ||||
| Cash And Equivalents | 402.12 K | ||||
| Total Debt | 6.65 M | ||||
| Debt To Equity | 0.53 % | ||||
| Current Ratio | 1.64 X | ||||
| Book Value Per Share | 0.20 X | ||||
| Cash Flow From Operations | (1.09 M) | ||||
| Earnings Per Share | 0.04 X | ||||
| Market Capitalization | 41.01 M | ||||
| Total Asset | 35.65 M | ||||
| Retained Earnings | (36.91 M) | ||||
| Working Capital | 17.95 M | ||||
About Microbix Biosystems Performance
By examining Microbix Biosystems' fundamental ratios, stakeholders can obtain critical insights into Microbix Biosystems' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Microbix Biosystems is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 267.28 | 287.41 | |
| Return On Capital Employed | (0.08) | (0.08) |
Things to note about Microbix Biosystems performance evaluation
Checking the ongoing alerts about Microbix Biosystems for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Microbix Biosystems help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Microbix Biosystems generated a negative expected return over the last 90 days | |
| Microbix Biosystems has some characteristics of a very speculative penny stock | |
| The company reported the revenue of 16.51 M. Net Loss for the year was (39.48 K) with profit before overhead, payroll, taxes, and interest of 11.12 M. | |
| Microbix Biosystems has accumulated about 402.12 K in cash with (1.09 M) of positive cash flow from operations. | |
| Roughly 14.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from news.google.com: Stocks In Play Microbix Biosystems Inc. - Barchart |
- Analyzing Microbix Biosystems' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Microbix Biosystems' stock is overvalued or undervalued compared to its peers.
- Examining Microbix Biosystems' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Microbix Biosystems' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Microbix Biosystems' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Microbix Biosystems' stock. These opinions can provide insight into Microbix Biosystems' potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Microbix Stock
Microbix Biosystems financial ratios help investors to determine whether Microbix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Microbix with respect to the benefits of owning Microbix Biosystems security.